LOGO.png
Nemaura Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
September 01, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable...
LOGO.png
Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021
August 16, 2021 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021
July 12, 2021 08:15 ET | Nemaura Medical, Inc
Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
LOGO.png
Nemaura Medical Issues Letter to Shareholders Following April 28 Shareholder Update Call
April 29, 2021 08:04 ET | Nemaura Medical, Inc
Loughborough, England, April 29, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Launches BEAT®diabetes Smartphone App on Android and iOS Platforms; Begins Pilot Distribution of proBEAT™ Sensors
April 13, 2021 08:05 ET | Nemaura Medical, Inc
Loughborough, England, April 13, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Retains Paul Kennedy as Advisor for International Growth Opportunities and Member of the Executive Advisory Board
March 25, 2021 08:10 ET | Nemaura Medical, Inc
Loughborough, England, March 25, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Logo (3).png
Sleep Apnea Devices Market Worth $12.9 billion by 2027- Exclusive Report by Meticulous Research®
May 11, 2020 03:35 ET | Meticulous Market Research Pvt. Ltd.
London, May 11, 2020 (GLOBE NEWSWIRE) -- According to a new market research report titled “Sleep Apnea Devices Market by Type (Therapeutic Devices (CPAP, APAP, BPAP, ASV, Oral Appliances, Masks)),...
Reports and Data.jpeg-01
Respiratory Care Devices Market To Reach USD 37.04 Billion By 2027 | Reports and Data
April 02, 2020 15:00 ET | Reports and Data
New York, April 02, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Respiratory Care Devices Market valued at USD 18.41 Billion in 2019 and is expected to...
fior-markets-logo.jpg
Global Sleep Apnea Devices Market is Expected to Reach USD 10.6 Billion by 2025 : Fior Markets
February 21, 2020 11:00 ET | Fior Markets
Newark, NJ, Feb. 21, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global sleep apnea devices market is expected to grow from USD 5.2 Billion in 2017 to USD 10.6 Billion...
Reports and Data.jpeg-01
Medical Processing Seals Films Market To Reach USD 2.02 Billion By 2026 | Reports And Data
September 05, 2019 12:35 ET | Reports and Data
New York, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Increasing incorporation of Managed Equipment Services, enhanced Medical Services in Developing nations, and the rising demand for medical equipment...